Pranav Preman
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
APOE3 and APOE4 human astrocytes differentially modulate Alzheimer's disease pathology and microglial responses in chimeric mice.
Journal: Cell reports
Published: February 04, 2026
Divergent Effects of APOE3 and APOE4 Human Astrocytes on Key Alzheimer's Disease Hallmarks in Chimeric Mice.
Journal: bioRxiv : the preprint server for biology
Published: February 20, 2025
Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge.
Journal: Brain communications
Published: July 06, 2024
APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia.
Journal: EMBO molecular medicine
Published: April 24, 2024
A neuron-specific interaction between Alzheimer's disease risk factors SORL1, APOE, and CLU.
Journal: Cell reports
Published: August 23, 2023
Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-β pathology.
Journal: Nature neuroscience
Published: November 28, 2022
Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer's disease.
Journal: Cell reports
Published: May 17, 2022
Astrocytes in Alzheimer's Disease: Pathological Significance and Molecular Pathways.
Journal: Cells
Published: January 27, 2021
Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques.
Journal: Molecular neurodegeneration
Published: November 19, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026